Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals

被引:0
|
作者
Jagpreet Chhatwal
Tianhua He
Maria A. Lopez-Olivo
机构
[1] Harvard Medical School,Institute for Technology Assessment, Massachusetts General Hospital
[2] Tsinghua University School of Medicine,Department of General Internal Medicine
[3] The University of Texas,undefined
[4] MD Anderson Cancer Center,undefined
来源
PharmacoEconomics | 2016年 / 34卷
关键词
Sustained Virological Response Rate; Telaprevir; Sofosbuvir; Boceprevir; Consolidate Health Economic Evaluation Reporting Standard;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:551 / 567
页数:16
相关论文
共 50 条
  • [1] Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals
    Chhatwal, Jagpreet
    He, Tianhua
    Lopez-Olivo, Maria A.
    PHARMACOECONOMICS, 2016, 34 (06) : 551 - 567
  • [2] COST-EFFECTIVENESS OF DIRECT-ACTING ANTIVIRALS FOR HEPATITIS C TREATMENT: A SYSTEMATIC REVIEW OF 227 ANALYSES
    Chhatwal, J.
    He, T.
    Hur, C.
    Lopez-Olivo, M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S774 - S775
  • [3] Direct-acting antivirals for hepatitis C treatment: effectiveness versus cost-effectiveness
    Chhatwal, Jagpreet
    FUTURE VIROLOGY, 2015, 10 (08) : 929 - 932
  • [4] Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6
    He, T.
    Lopez-Olivo, M. A.
    Hur, C.
    Chhatwal, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (08) : 711 - 721
  • [5] COST-EFFECTIVENESS OF DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C VIRUS IN RUSSIA
    Ignatyeva, V
    Pyadushkina, E.
    Derkach, E., V
    VALUE IN HEALTH, 2019, 22 : S646 - S647
  • [6] Cost-effectiveness of direct-acting antivirals for chronic hepatitis C
    Gaby Sroczynski
    Uwe Siebert
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 572 - 574
  • [7] VIRAL HEPATITIS Cost-effectiveness of direct-acting antivirals for chronic hepatitis C
    Sroczynski, Gaby
    Siebert, Uwe
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (10) : 572 - 574
  • [8] A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD
    Balk, Ethan M.
    Adam, Gaelen P.
    Jadoul, Michel
    Martin, Paul
    Gordon, Craig E.
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (02): : 240 - 253
  • [9] Cost and cost-effectiveness of a simplified treatment model with direct-acting antivirals for chronic hepatitis C in Cambodia
    Walker, Josephine G.
    Mafirakureva, Nyashadzaishe
    Iwamoto, Momoko
    Campbell, Linda
    San Kim, Chamroeun
    Hastings, Reuben A.
    Doussett, Jean-Philippe
    Le Paih, Mickael
    Balkan, Suna
    Marquardt, Tonia
    Maman, David
    Loarec, Anne
    Coast, Joanna
    Vickerman, Peter
    LIVER INTERNATIONAL, 2020, 40 (10) : 2356 - 2366
  • [10] Measure of adherence to direct-acting antivirals as a predictor of the effectiveness of hepatitis C treatment
    María Ángeles Campos Fernández de Sevilla
    Marta Gallego Úbeda
    Maria Tovar Pozo
    Emilio García-Cabrera
    Beatriz Monje García
    Federico Tutau Gómez
    Laura Delgado Téllez de Cepeda
    Irene Iglesias-Peinado
    International Journal of Clinical Pharmacy, 2019, 41 : 1545 - 1554